Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1986
Pharmacokinetics of T-2 toxin and its metabolite HT-2 toxin, after intravenous administration in dogs
A Sintov, M Bialer, B Yagen
Memory & Cognition
|
November 5, 2025
Deep distortions in faces and places
Daniel M Bialer, C J Brainerd
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
December 1, 1985
Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects
M Bialer, K Salame, I Raz
Biopharmaceutics & Drug Disposition
|
October 1, 1994
Pharmacokinetic profile of conjugated verrucarol urinary metabolites in dogs
S Barel, B Yagen, M Bialer
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
February 1, 1990
Identification of glucose conjugates as major urinary metabolites of cannabidiol in the dog
E Samara, M Bialer, D J Harvey
Pharmaceutical Research
|
August 1, 1992
Pharmacokinetic analysis of the structural requirements for forming "stable" analogues of valpromide
A Haj-Yehia, S Hadad, M Bialer
Therapeutic Drug Monitoring
|
March 5, 1998
Does carbamazepine have a narrow therapeutic plasma concentration range?
M Bialer, R H Levy, E Perucca
Pharmaceutical Research
|
May 1, 1993
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs
A A Gabizon, Y Barenholz, M Bialer
Journal of Pharmaceutical Sciences
|
November 1, 1985
Relationship between protein binding and renal clearance of a new oral cephalosporin in the dog
A P Tonelli, M Bialer, A Yacobi
Biopharmaceutics & Drug Disposition
|
December 1, 1990
Pharmacokinetics of urinary metabolites of cannabidiol in the dog
E Samara, M Bialer, D J Harvey
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1986
Pharmacokinetics of T-2 toxin and its metabolite HT-2 toxin, after intravenous administration in dogs
A Sintov, M Bialer, B Yagen
Memory & Cognition
|
November 5, 2025
Deep distortions in faces and places
Daniel M Bialer, C J Brainerd
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
December 1, 1985
Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects
M Bialer, K Salame, I Raz
Biopharmaceutics & Drug Disposition
|
October 1, 1994
Pharmacokinetic profile of conjugated verrucarol urinary metabolites in dogs
S Barel, B Yagen, M Bialer
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
February 1, 1990
Identification of glucose conjugates as major urinary metabolites of cannabidiol in the dog
E Samara, M Bialer, D J Harvey
Pharmaceutical Research
|
August 1, 1992
Pharmacokinetic analysis of the structural requirements for forming "stable" analogues of valpromide
A Haj-Yehia, S Hadad, M Bialer
Therapeutic Drug Monitoring
|
March 5, 1998
Does carbamazepine have a narrow therapeutic plasma concentration range?
M Bialer, R H Levy, E Perucca
Pharmaceutical Research
|
May 1, 1993
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs
A A Gabizon, Y Barenholz, M Bialer
Journal of Pharmaceutical Sciences
|
November 1, 1985
Relationship between protein binding and renal clearance of a new oral cephalosporin in the dog
A P Tonelli, M Bialer, A Yacobi
Biopharmaceutics & Drug Disposition
|
December 1, 1990
Pharmacokinetics of urinary metabolites of cannabidiol in the dog
E Samara, M Bialer, D J Harvey
Page
of 14